| abstract |
The present invention relates to a kit for diagnosing diabetes or predicting the risk of developing diabetes, and to a diagnostic method using the same, for 175 genetic mutations previously reported in relation to type 2 diabetes and 56 genetic mutations that are associated with fasting blood sugar. By scoring the genetic risk and analyzing it in a complex manner, it is possible to select the high genetic risk group of type 2 diabetes using only the genetic information of each individual without additional tests such as age, sex, and environmental impact, and the high genetic risk group of type 2 diabetes. Depending on the selection, it can be used for customized treatment, treatment, and prevention. |